Funders › FL › Scott R Mackenzie Foundation Inc › 2023
Grants paid by Scott R Mackenzie Foundation Inc, tax year 2023
EIN 46-3383293 · Jacksonville, FL · Form 990-PF, Part XV · NTEE T22
In tax year 2023, Scott R Mackenzie Foundation Inc (EIN 46-3383293) reported 6 grants paid totaling $1,202,529. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2023
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2023 | Mount Desert Island Biological Laboratory Bar Harbor, ME | B | $450,000 | paid | THE BENEFACTOR DESIRES THAT GRANTEE SHALL USE THE GIFT TO CONTINUE THE PROJECT AWARDED IN 2022 TO ESTABLISH A NOVEL TREATMENT STRATEGY FOR DIABETIC KIDNEY DISEASE. PREVIOUS SUPPORT FROM THE MACKENZIE FOUNDATION IS ALLOWING MDI BIO LAB TO UNDERSTAND THE STRUCTURE AND FUNCTIONAL PARTS OF THE HPA2 MOLECULE AND ESTABLISH A BASELINE FROM WHICH TO FULLY UNDERSTAND ITS FUNCTION. BASED ON THIS ONGOING WORK, MDI BIO LAB NOW SEEKS TO INVESTIGATE THE EFFECT OF DIABETES IN A MODEL ORGANISM OF AGING (AFRICAN TURQUOISE KILLIFISH). SIMULTANEOUSLY, MDI BIO LAB ALSO PROPOSES TO USE THIS MODEL TO STUDY THE LOSS OF PERITUBULAR CAPILLARIES OBSERVED DURING KIDNEY AGING. | 202541299349101429 |
| 2023 | Emory University Grants Atlanta, GA | U | $250,000 | paid | THE BENEFACTOR DESIRES THAT GRANTEE SHALL USE THE GIFT TO OPTIMIZE AND VALIDATE A COMPUTATIONAL PATHOLOGY-BASED IMAGE RISK PREDICTOR (OVARISC) THAT PREDICTS OUTCOME AND RESPONSE IN ADVANCED OCA RECEIVING PRIMARY PLATINUM-BASED COMBINATION CHEMOTHERAPY, AND TO CONFIRM THE ASSOCIATION BETWEEN OVARISC SCORES AND RESPONSE TO ICI ON A BLINDED VALIDATION SET OBTAINED FROM AN INDEPENDENT CLINICAL TRIAL. | 202541299349101429 |
| 2023 | Hmh Hospitals Corporation Edison, NJ | B | $150,000 | paid | THE BENEFACTOR DESIRES THAT GRANTEE SHALL USE THE GIFT TO FOCUS ON QUANTIFYING SELECTIVE PRESSURES APPLIED BY NUCLEOTIDE DEPLETION AND GENOMIC STRESS IN ORDER TO DISSECT THE EVOLUTIONARY DYNAMICS OF CANCER CELLS ACROSS MULTIPLE TUMOR TYPES, INCLUDING LEUKEMIA, LYMPHOMA, MYELOMA, COLORECTAL CANCER, MELANOMA, AND RETINOBLASTOMA. | 202541299349101429 |
| 2023 | University of Florida Foundation Gainesville, FL | B | $149,584 | paid | THE BENEFACTOR DESIRES THAT GRANTEE SHALL USE THE GIFT TO IDENTIFY DEPENDENCIES OF TUMOR CELLS IN DEEP MARGINS BY PERFORMING SINGLE-CELL SEQUENCING ON LARGER COHORT OF TUMORS THE GRANTEE COLLECTED (N=28) AND TESTING THEIR FINDINGS IN MODEL SYSTEMS. THUS, THE STUDY WOULD OPEN NEW AVENUES FOR THERAPIES TARGETING SPECIFIC TRAITS WITHIN TUMOR CELLS DRIVING RECURRENCE, AND FOR IMPROVED STRATEGIES RELEASING THE HOST IMMUNE SYSTEM AGAINST GLIOBLASTOMA. | 202541299349101429 |
| 2023 | University of Florida Foundation Gainesville, FL | B | $125,000 | paid | THE BENEFACTOR DESIRES THAT GRANTEE SHALL USE THE GIFT TO SEEK TO DEFINE TREATMENT REGIMENS OF BLOOD THINNING MEDICATIONS ASSOCIATED WITH REDUCED RISK OF RECURRENT HEART ATTACKS, WHICH MAY INCLUDE THE USE OF THE MORE POTENT BLOOD THINNER TICAGRELOR ALSO IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE. | 202541299349101429 |
| 2023 | University of Miami College of Medicine Coral Gables, FL | U | $77,945 | paid | THE BENEFACTOR DESIRES THAT GRANTEE SHALL USE THE GIFT TO UTILIZE GENERATIVE ADVERSARIAL NETWORK (GAN) MODELS TO CREATE HIGH-QUALITY SYNTHETIC IMAGES REPRESENTING VARIOUS PROSTATE CANCER (PCA) GRADES. THESE IMAGES WILL BE TAILORED TO ACCOUNT FOR THE MORPHOLOGICAL AND GENOMIC GRANULARITY ASSOCIATED WITH EACH GLEASON GRADE WHILE REQUIRING SIGNIFICANTLY SMALLER TRAINING DATA SAMPLES. PRELIMINARY DATA INDICATES THAT THIS APPROACH CONSIDERABLY ENHANCES AI MODELS' PROGNOSTIC CAPABILITIES FOR PCA. | 202541299349101429 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990-PF e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.